Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.33 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6369906 | 0.96 | TSHR (0.50) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL9292699 | 0.96 | — | — | |
| SCHEMBL811 | 0.96 | — | — | |
| SCHEMBL625170 | 0.92 | — | — | |
| SCHEMBL3441314 | 0.92 | — | — | |
| Barium SCHEMBL11668415 | 0.92 | — | — | |
| SCHEMBL11720580 | 0.92 | — | — | |
| Ammonia Solution, Strong SCHEMBL9903410 | 0.92 | — | — | |
| Phosphine SCHEMBL20135762 | 0.92 | — | — | |
| SCHEMBL1617151 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115417939-B | Acrylonitrile high-regularity high-molecular-weight anionic polymerization process initiated by propionitrile anions | 新创碳谷集团有限公司 | 2023-05-19 | — | — | CN | claimed |
| CN-115417939-A | High-regularity high-molecular-weight anion polymerization process for acrylonitrile initiated by propionitrile anion | 新创碳谷集团有限公司 | 2022-12-02 | — | — | CN | claimed |
| WO-2024147631-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 에스에프씨 주식회사 | 2024-07-11 | — | — | WO | disclosed |
| CN-113195508-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-06-28 | — | — | CN | disclosed |
| US-12006336-B2 | Polycyclic compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2024-06-11 | — | — | US | disclosed |
| CN-112106216-B | Organic light emitting device | 株式会社LG化学 | 2024-05-31 | — | — | CN | disclosed |
| CN-113994497-B | Organic light emitting device | 株式会社LG化学 | 2024-05-31 | — | — | CN | disclosed |
| US-11991922-B2 | Organic light-emitting device | LG CHEM, LTD. (KR) | 2024-05-21 | — | — | US | disclosed |
| CN-118005666-A | Boron-nitrogen polycyclic compound and organic electroluminescent device comprising same | 石家庄诚志永华显示材料有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-114621270-B | Condensed ring aromatic compound and application thereof in electroluminescent device | 清华大学 | 2024-04-12 | — | — | CN | disclosed |
| CN-114621269-B | Condensed ring aromatic compound and application thereof in electroluminescent device | 清华大学 | 2024-04-09 | — | — | CN | disclosed |
| WO-2020022770-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2020-01-30 | — | — | WO | disclosed |
| CN-104817060-B | A kind of preparation method of two dimension lithium doping Graphene | 常州大学 | 2016-08-17 | — | — | CN | disclosed |
| CN-101821267-B | Compounds for the treatment of hepatitis c | BRISTOL MYERS SQUIBB CO | 2013-07-10 | — | — | CN | disclosed |
| CN-101503413-B | Preparation of 5,6-dihydro-6-methieno [2,3-b] thiopyran-2-sulfonic acid amide-4-keto | NANCHANG INST OF AERONAUTICAL TECHNOLOGY | 2011-10-12 | — | — | CN | disclosed |
| CN-101821267-A | Compounds for the treatment of hepatitis c | BRISTOL MYERS SQUIBB CO | 2010-09-01 | — | — | CN | disclosed |
| CN-101503413-A | Preparation of 5,6-dihydro-6-methieno [2,3-b] thiopyran-2-sulfonic acid amide-4-keto | NANCHANG INST OF AERONAUTICAL (CN) | 2009-08-12 | — | — | CN | disclosed |
| CN-101503412-A | Preparation of 5,6- dihydro-4-hydroxy-(S)-6- methylthieno [2,3-b] thiopyran | NANCHANG INST OF AERONAUTICAL (CN) | 2009-08-12 | — | — | CN | disclosed |
| CN-1651418-A | Human epidermis growth factor acceptor 2 tyrosinase inhibitor | UNIV ZHONGSHAN (CN) | 2005-08-10 | — | — | CN | disclosed |
| US-5189048-A | Hypotensive agents | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12006336-B2 | Polycyclic compound and organic light-emitting device comprising same | CCNL2, CRY2, CRY1 | TSHR 3742/4885LMNA 880/4885THRB 3901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.